Figure 1.
Percentage of SARS-CoV-2 binding inhibition (NAbs) (A) and anti-S-RBD levels (B) for the study population. The asterisk (*) denotes a statistically significant difference between the ninth month levels and the previous timepoints (P < 0.05). The boxplot borders correspond to the distribution’s quartiles. NAbs = neutralizing antibodies; RBD = receptor binding domain.